Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00930904 · ClinicalTrials.gov registry record
Model 4196 Left Ventricular (LV) Lead Chronic Performance Study
A clinical trial, sponsored by Medtronic.
- Completed
- Registry status
- 1,847
- Enrollment target
NCT00930904 is a clinical trial that has completed, run by Medtronic. The registered enrollment target is 1,847 participants.
The verdict
NCT00930904 has completed, sponsored by Medtronic.
- COMPLETED
- Registry status
- 1,847 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate long-term performance of the 4196 LV Lead. This evaluation is based on the number of lead-related complications occurring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the Model 4196 LV Lead and is integrated within the Product Surveillance Registry (PAN Registry).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,847 participants |
| Start Date | 2009-06 |
| Est. Completion | 2017-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00930904
The ClinicalTrials.gov registry entry for NCT00930904 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,847 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00930904 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00930904 about?
NCT00930904 is a clinical study titled "Model 4196 Left Ventricular (LV) Lead Chronic Performance Study". The purpose of this study is to evaluate long-term performance of the 4196 LV Lead. This evaluation is based on the number of lead-related complications occurring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study ...
What is the current status of trial NCT00930904?
This trial is currently completed. The enrollment target is 1,847 participants. The study started on 2009-06. Estimated completion is 2017-04.
Who is sponsoring clinical trial NCT00930904?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.